Gum tragacanth-polyvinyl alcohol cryogel and xerogel blends for oral delivery of silymarin: Structural characterization and mucoadhesive property

Advances in the use of nanotechnology for treating gout

Gout is a commonly occurring form of inflammatory arthritis caused by persistently elevated levels of uric acid. Its incidence rate rises with the increases of living standards and poor dietary habits, which has a considerable impact on the quality of life of the patients. Although there is a wide assortment of drugs available for the management of gout, the effectiveness and security of these drugs are limited by their poor chemical stability and insufficient targeting. Therefore, development of effective nanomedicine systems to overcome these problems and treat gout becomes a high priority. This review provides a detailed introduction research progress on developing advanced nanomedicines using polymers, hydrogel, nanocapsules, lipids, bionic vesicles, inorganic artificial organelles and electronically controlled conveyor systems carriers to improve gout therapy.

Tragacanth gum hydrogels with cellulose nanocrystals: A study on optimizing properties and printability

This study investigates a novel all-polysaccharide hydrogel composed of tragacanth gum (TG) and cellulose nanocrystals (CNCs), eliminating the need for toxic crosslinkers. Designed for potential tissue engineering applications, these hydrogels were fabricated using 3D printing and freeze-drying techniques to create scaffolds with interconnected macropores, facilitating nutrient transport. SEM images revealed that the hydrogels contained macropores with a diameter of 100-115 μm. Notably, increasing the CNC content within the TG matrix (30-50 %) resulted in a decrease in porosity from 83 % to 76 %, attributed to enhanced polymer-nanocrystal interactions that produced denser networks. Despite the reduced porosity, the hydrogels demonstrated high swelling ratios (890-1090 %) due to the high water binding capacity of the hydrogel. Mechanical testing showed that higher CNC concentrations significantly improved compressive strength (27.7-49.5 kPa) and toughness (362-707 kJ/m3), highlighting the enhanced mechanical properties of the hydrogels. Thermal analysis confirmed stability up to 400 °C and verified ionic crosslinking with CaCl₂. Additionally, hemolysis tests indicated minimal hemolytic activity, affirming the biocompatibility of the TG/CNC hydrogels. These findings highlight the potential of these hydrogels as advanced materials for 3D-printed scaffolds and injectable hydrogels, offering customizable porosity, superior mechanical strength, thermal stability, and biocompatibility.

Dispersion of halloysite nanotube/lipase nanohybrids as nanofillers into polyvinyl alcohol-sodium alginate cryogel: Characterization and bio-catalytic activity analysis

The purpose of this study is to formulate and characterize the cryogels containing halloysite nanotube (HNT)/lipase nanohybrid (NH-cryogel) in comparison to pure cryogels as well as cryogels containing lipase (lipase-cryogel). The cryogels were synthesized using polyvinyl alcohol (PVA) and sodium alginate (SA). The products are tested to explore the influence of the HNT/lipase nanohybride (NH) as nanofillers on the cryogel properties using methods such as swelling degree, water uptake measurement, TGA, XRD, FESEM and FTIR. Additionally, the effects of cryogels on the stability and biocatalytic activities of lipase and NH, were studied and compared to the free lipase to evaluate their potential applications as enzyme carriers. The addition of nanofillers into the cryogel improved is thermal stability. The results implied that NH-cryogel had better enzyme activity than lipase-cryogel and free lipase at different temperatures and pH values. The NH-cryogel residual activity was 85.5 % after ten cycles of reuse while lipase-cryogel showed lower residual activity (60.3 %). Furthermore, the NH-cryogel retained 81.1 % of its residual activity while this was 51.0 % for lipase-cryogel after thirty days of storage. Therefore, the presented results in this study provide a pathway to show that produced nano-composite cryogels could be useful substances for food and pharmaceutical industries applications.

Chondroitin sulfate-modified tragacanth gum-gelatin composite nanocapsules loaded with curcumin nanocrystals for the treatment of arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease of yet undetermined etiology that is accompanied by significant oxidative stress, inflammatory responses,  and damage to joint tissues. In this study, we designed chondroitin sulfate (CS)-modified tragacanth gum-gelatin composite nanocapsules (CS-Cur-TGNCs) loaded with curcumin nanocrystals (Cur-NCs), which rely on the ability of CS to target CD44 to accumulate drugs in inflamed joints. Cur was encapsulated in the form of nanocrystals into tragacanth gum-gelatin composite nanocapsules (TGNCs) by using an inborn microcrystallization method, which produced CS-Cur-TGNCs with a particle size of approximately 80 ± 11.54 nm and a drug loading capacity of 54.18 ± 5.17%. In an in vitro drug release assay, CS-Cur-TGNCs showed MMP-2-responsive properties. During the treatment of RA, CS-Cur-TGNCs significantly inhibited oxidative stress, promoted the polarization of M2-type macrophages to M1-type macrophages, and decreased the expression of inflammatory factors (TNF-α, IL-1β, and IL-6). In addition, it also exerted excellent anti-inflammatory effects, and significantly alleviated the swelling of joints during the treatment of gouty arthritis (GA). Therefore, CS-Cur-TGNCs, as a novel drug delivery system, could lead to new ideas for clinical therapeutic regimens for RA and GA.

Pectin Nanoporous Structures Prepared via Salt-Induced Phase Separation and Ambient Azeotropic Evaporation Processes

Polysaccharide nanoporous structures are suitable for various applications, ranging from biomedical scaffolds to adsorption materials, owing to their biocompatibility and large surface areas. Pectin, in particular, can create 3D nanoporous structures in aqueous solutions by binding with calcium cations and creating nanopores by phase separation; this process involves forming hydrogen bonds between alcohols and pectin chains in water and alcohol mixtures and the resulting penetration of alcohols into calcium-bound pectin gels. However, owing to the dehydration and condensation of polysaccharide chains during drying, it has proven to be challenging to maintain the 3D nanoporous structure without using a freeze-drying process or supercritical fluid. Herein, we report a facile method for creating polysaccharide-based xerogels, involving the co-evaporation of water with a nonsolvent (e.g., a low-molecular-weight hydrophobic alcohol such as isopropyl or n-propyl alcohol) at ambient conditions. Experiments and coarse-grained molecular dynamics simulations confirmed that salt-induced phase separation and hydrogen bonding between hydrophobic alcohols and pectin chains were the dominant processes in mixtures of pectin, water, and hydrophobic alcohols. Furthermore, the azeotropic evaporation of water and alcohol mixed in approximately 1:1 molar ratios was maintained during the natural drying process under ambient conditions, preventing the hydration and aggregation of the hydrophilic pectin chains. These results introduce a simple and convenient process to produce 3D polysaccharide xerogels under ambient conditions.

Cryogels: Advancing Biomaterials for Transformative Biomedical Applications

Cryogels, composed of synthetic and natural materials, have emerged as versatile biomaterials with applications in tissue engineering, controlled drug delivery, regenerative medicine, and therapeutics. However, optimizing cryogel properties, such as mechanical strength and release profiles, remains challenging. To advance the field, researchers are exploring advanced manufacturing techniques, biomimetic design, and addressing long-term stability. Combination therapies and drug delivery systems using cryogels show promise. In vivo evaluation and clinical trials are crucial for safety and efficacy. Overcoming practical challenges, including scalability, structural integrity, mass transfer constraints, biocompatibility, seamless integration, and cost-effectiveness, is essential. By addressing these challenges, cryogels can transform biomedical applications with innovative biomaterials.

Characterization and Morphology of Nanocomposite Hydrogels with a 3D Network Structure Prepared Using Attapulgite-Enhanced Polyvinyl Alcohol

In this investigation, purified attapulgite (ATT) and polyvinyl alcohol (PVA) were utilized to fabricate nanocomposite hydrogels and a xerogel, with a focus on studying the impact of minor additions of ATT on the properties of the PVA nanocomposite hydrogels and xerogel. The findings demonstrated that at a concentration of 0.75% ATT, the water content and gel fraction of the PVA nanocomposite hydrogel reached their peak. Conversely, the nanocomposite xerogel with 0.75% ATT reduced its swelling and porosity to the minimum. SEM and EDS analyses revealed that when the ATT concentration was at or below 0.5%, nano-sized ATT could be evenly distributed in the PVA nanocomposite xerogel. However, when the concentration of ATT rose to 0.75% or higher, the ATT began to aggregate, resulting in a decrease in porous structure and the disruption of certain 3D porous continuous structures. The XRD analysis further affirmed that at an ATT concentration of 0.75% or higher, a distinct ATT peak emerged in the PVA nanocomposite xerogel. It was observed that as the content of ATT increased, the concavity and convexity of the xerogel surface, as well as the surface roughness, decreased. The results also confirmed that the ATT was evenly distributed in the PVA, and a combination of hydrogen bonds and ether bonds resulted in a more stable gel structure. The tensile properties exhibited that when compared with pure PVA hydrogel, the maximum tensile strength and elongation at break were achieved at an ATT concentration of 0.5%, indicating increases of 23.0% and 11.8%, respectively. The FTIR analysis results showed that the ATT and PVA could generate an ether bond, further confirming that ATT could enhance the PVA properties. The TGA analysis showed that the thermal degradation temperature peaked when the ATT concentration was at 0.5%, providing further evidence that the compactness of the nanocomposite hydrogel and the dispersion of the nanofiller was superior, contributing to a substantial increase in the mechanical properties of the nanocomposite hydrogel. Finally, the dye adsorption results displayed a significant rise in dye removal efficiency for methylene blue with the increase in the ATT concentration. At an ATT concentration of 1%, the removal efficiency rose by 103% compared with that of the pure PVA xerogel.

A review on tragacanth gum: A promising natural polysaccharide in drug delivery and cell therapy

Tragacanth is an abundant natural gum extracted from wounds created in some plants and is dried for use in various applications from industry to biomedicines. It is a cost-effective and easily accessible polysaccharide with desirable biocompatibility and biodegradability, drawing much attention for use in new biomedical applications such as wound healing and tissue engineering. Moreover, this anionic polysaccharide with a highly branched structure has been used as an emulsifier and thickening agent in pharmaceutical applications. In the following, this gum has been interested as an appealing biomaterial for producing engineering tools in drug delivery. Furthermore, the biological properties of tragacanth gum have made it a favorable biomaterial in cell therapies, especially for bone tissue engineering. This review aims to discuss the recent studies on this natural gum as a potential carrier for different drugs and cells.

Smart vaginal bilayer films of Tenofovir based on Eudragit® L100/natural polymer for the prevention of the sexual transmission of HIV

In the absence of an effective vaccine, vaginal microbicides are essential for preventing the sexual transmission of HIV to women. Antiretroviral vaginal films have emerged as promising choices, especially those offering mucoadhesivity and controlled drug release. Tenofovir-loaded bilayer films based on Eudragit® L100 (EL100) and a biopolymer - gum arabic, karaya gum, pectin or tragacanth gum - were developed in a single-stage process. Cytotoxicity studies in three human cell lines indicated no toxicity of the excipients at the concentrations tested. Raman spectroscopy and SEM confirmed the formation of the two layers and their anchoring. Texture analysis showed no major differences between the batches. The swelling of the film is conditioned by its biopolymer nature and by the amount of EL100, which acts as structuring agent thus enhancing swelling. Tragacanth gum-based batches showed high mucoadhesion regardless the amount of EL100. The controlled release of Tenofovir in simulated vaginal fluid was faster in the presence of simulated seminal fluid due to the dissolution of EL100. Films containing 400 mg of EL100 and tragacanth gum are promising candidates for future studies, as they could sexually safeguard women from HIV for at least one week and ensure greater protection during intercourse.

Gastro-retentive drug delivery systems: a recent update on clinical pertinence and drug delivery

Gastro-retentive drug delivery systems are some of the best technologies delivered through oral route. These mainly came into picture for their effective local action in the GI region, specifically for the drugs with narrow absorption window. In the recent decades, several technologies have evolved showing different mechanisms for retaining the drug in GI region for longer duration with increased bioavailability. Floatable, mucoadhesive, swelable, magnetic, nanofibrous, high-density, and expandable systems have been investigated extensively as the potential gastro-retentive strategies. The advances in the technologies studied, their clinical pertinence, and methods of drug delivery are described in this review with their immense future utilities. Their entry into the pharmaceutical market is a huge matter to look into as most of the studied strategies are facing problems and hence are underrated to overcome the clinical trials. Their success in the clinical trials are enormously required for gaining their access into the pharmaceutical market. Selection of the right technology for the right purpose through the right mechanism of action is to be done for obtaining the system with desired activity.

Gum tragacanth-polyvinyl alcohol aerogel for oral delivery of silymarin

This study reports for the first time the fabrication of highly porous aerogels of mixed gum tragacanth-polyvinyl alcohol (GT-PVA) for loading and oral delivery of silymarin (SM). Various analytical techniques were used to investigate changes in the physical, textural, mechanical and microstructural properties of aerogels as affected by blending ratio and vacuum impregnation (VI) of SM. Results showed that the mixing ratio of 1:1 led to aerogels of larger surface area (1029.20 m²·g^-1) and superior physicochemical properties. However, at mixing ratio of 3:1 (GT:PVA) higher loading capacity (45.57% ± 2.3%) was obtained. SM loading, on the other hand, had an adverse effect on the porosity, microstructure and physical attributes of aerogels transforming them from meso-porous to macro-porous structures. The release rate of SM in simulated gastrointestinal media was found to follow Korsmeyere-Peppas model.

Recent progress in the industrial and biomedical applications of tragacanth gum: A review

Natural polymers have distinct advantages over synthetic polymers because of their abundance, biocompatibility, and biodegradability. Tragacanth gum, an anionic polysaccharide, is a natural polymer which is derived from renewable sources. As a biomaterial, tragacanth gum has been used in industrial settings such as food packaging and water treatment, as well as in the biomedical field as drug carriers and for wound healing purposes. The present review provides an overview on the state-of-the-art in the field of tragacanth gum applications. The structure, properties, cytotoxicity, and degradability as well as the recent advances in industrial and biomedical applications of tragacanth gum are reviewed to offer a backdrop for future research.

Tree gum-based renewable materials: Sustainable applications in nanotechnology, biomedical and environmental fields

The prospective uses of tree gum polysaccharides and their nanostructures in various aspects of food, water, energy, biotechnology, environment and medicine industries, have garnered a great deal of attention recently. In addition to extensive applications of tree gums in food, there are substantial non-food applications of these commercial gums, which have gained widespread attention due to their availability, structural diversity and remarkable properties as 'green' bio-based renewable materials. Tree gums are obtainable as natural polysaccharides from various tree genera possessing exceptional properties, including their renewable, biocompatible, biodegradable, and non-toxic nature and their ability to undergo easy chemical modifications. This review focuses on non-food applications of several important commercially available gums (arabic, karaya, tragacanth, ghatti and kondagogu) for the greener synthesis and stabilization of metal/metal oxide NPs, production of electrospun fibers, environmental bioremediation, bio-catalysis, biosensors, coordination complexes of metal-hydrogels, and for antimicrobial and biomedical applications. Furthermore, polysaccharides acquired from botanical, seaweed, animal, and microbial origins are briefly compared with the characteristics of tree gum exudates.